Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79,794,643
-
Total 13F shares
-
22,482,225
-
Share change
-
+4,718,854
-
Total reported value
-
$119,275,778
-
Put/Call ratio
-
12%
-
Price per share
-
$5.30
-
Number of holders
-
121
-
Value change
-
+$25,340,075
-
Number of buys
-
71
-
Number of sells
-
31
Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q4 2024
As of 31 Dec 2024,
Niagen Bioscience, Inc. - Common Stock (NAGE) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,482,225 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Tieton Capital Management, LLC, ICONIQ Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, D. E. Shaw & Co., Inc., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and Connor, Clark & Lunn Investment Management Ltd..
This page lists
121
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.